Surging Demand Triggers Early-Year Shortages of Lilly’s Obesity Drug Mounjaro
SEOUL, Feb. 2 (Korea Bizwire) – Eli Lilly’s blockbuster obesity drug Mounjaro showed signs of supply strain in South Korea at the start of the year, as surging demand outpaced deliveries, according to pharmaceutical market data. Data released Sunday by BRP Insight, a drug supply analytics platform, indicated that the 2.5-milligram starter dose of Mounjaro [...]

